-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The new crown pneumonia epidemic has lasted for more than a year, and it has caused severe damage to the global economy and people's health
Recently, Peking University, Lu Lin Yuanshi team in top international medical journal "The Lancet" ( Lancet ) published a sub Eclinical Medicine published a paper entitled " Mental and Neurological Disorders and Risk of COVID-19 susceptibility, illness and mortality Severity: A Systematic Review , meta-analysis and call for action " the latest research
Article screenshot
The study retrieved relevant articles from 5 databases including PubMed, Web of Science, and Embase as of July 2021, and finally included 149 observational studies from 21 countries, a total of more than 200 million survey subjects, including 8,900 Ten thousand patients with new coronary pneumonia.
Studies have found that before the new crown infection, people with neuropsychiatric diseases will increase the risk of contracting new coronary pneumonia.
Mental and neurological diseases are related to the susceptibility and poor prognosis of new coronary pneumonia, and timely prevention and intervention are required
The article called for the role of neuropsychiatric diseases in the new coronary pneumonia epidemic to not be ignored, and the detection and management of patients with mental and neurological disorders during the epidemic is very important
Citation information: Liu L, Ni SY, Yan W, et al.